• Explore /
  • Poster
  • / The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab.

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab.

Abstract Poster

Authors

null

Stephen John Clarke

University of Sydney, St. Leonards, Australia

Stephen John Clarke , Matthew E. Burge , Kynan Feeney , Kristian Jones , Peter Gibbs , Mark P. Molloy , Gavin M. Marx , Timothy Jay Price , William Reece , Eva Segelov , Niall C. Tebbutt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01588990

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 719)

DOI

10.1200/JCO.2018.36.4_suppl.719

Abstract #

719

Poster Bd #

H8

Abstract Disclosures

Similar Posters

First Author: Akihisa Matsuda

First Author: Lee Schwartzberg

First Author: Satoshi Yuki

First Author: Lucy Xiaolu Ma